<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="2 weeks after the onset of symptoms. At that time," exact="methylprednisolone" post="was able to reduce levels of IL-8, MCP-1, and"/>
 <result pre="(Th2 response). In parallel, a letter reported that use of" exact="methylprednisolone" post="(1â€&quot;2â€‰mg/kg/day for 5â€&quot;7 days) in 26 patients with severe"/>
 <result pre="trial of critically ill patients with COVID-19 demonstrated benefit of" exact="dexamethasone" post="(orally or intravenously, 6â€‰mg once daily for 10 days)"/>
 <result pre="treatment. Alternatively, pregnant or breastfeeding women were randomized to receive" exact="prednisolone" post="(orally, 40â€‰mg) or hydrocortisone (intravenously, 80â€‰mg twice daily). The"/>
 <result pre="breastfeeding women were randomized to receive prednisolone (orally, 40â€‰mg) or" exact="hydrocortisone" post="(intravenously, 80â€‰mg twice daily). The RECOVERY trial enrolled 6425"/>
 <result pre="institutes of health are updating their guidelines to recommend that" exact="dexamethasone" post="be administered to COVID-19-patients with hypoxemic respiratory failure (World"/>
 <result pre="to advise glucocorticoids rather than no glucocorticoids (preferably dexamethasone, alternatively" exact="methylprednisolone" post="or prednisone) in hospitalized patients with severe COVID-19. Steroid"/>
 <result pre="A study of 30 patients with SARS-CoV-1 infection treated with" exact="methylprednisolone" post="showed that the initial stage of the disease is"/>
 <result pre="infections. Finally, in a study of SARS-CoV-1 patients in which" exact="ribavirin" post="and hydrocortisone therapy were compared versus placebo, suggested that"/>
 <result pre="in a study of SARS-CoV-1 patients in which ribavirin and" exact="hydrocortisone" post="therapy were compared versus placebo, suggested that corticosteroid administration"/>
 <result pre="(iv) the dose administered should be low to moderate (â‰¤0.5âˆ’1â€‰mg/kg/day" exact="methylprednisolone" post="or equivalent), and the duration short (â‰¤7 days). Additionally,"/>
 <result pre="Also, clinicians should be aware of possible drugâ€&quot;drug interactions, since" exact="dexamethasone" post="is a moderate inducer of cytochrome P450 (CYP)3A4, and"/>
 <result pre="septic shockN. Engl. J. Med.378201879780829347874 WangY.JiangW.HeQ.WangC.WangB.ZhouP.DongN.TongQ.A retrospective cohort study of" exact="methylprednisolone" post="therapy in severe patients with COVID-19 pneumoniaSig. Transduct. Target"/>
</results>
